The decrease in the percentage of M2 TAMs visible by cytometry was also confirmed by the decrease in CCL17 and CCL22 mRNA (M2 macrophages markers), as well as CXCR2 mRNA in the tumor (Fig. 5e). The gene discussed is CCL22; the disease is neoplasm.